| Schedule of Segment Reporting Information, by Segment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Biopharmaceuticals |
|
Bioprocessing |
|
|
|
|
Three Months Ended September 30, 2021 (in thousands) |
|
(iBio, Inc.) |
|
(iBio CDMO) |
|
Eliminations |
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues - external customers |
|
$ |
84 |
|
|
127 |
|
$ |
— |
|
$ |
211 |
Revenues - intersegment |
|
|
82 |
|
|
455 |
|
|
(537) |
|
|
— |
Cost of goods sold |
|
|
— |
|
|
40 |
|
|
— |
|
|
40 |
Gross profit |
|
|
166 |
|
|
542 |
|
|
(537) |
|
|
171 |
Research and development |
|
|
1,521 |
|
|
1,467 |
|
|
(477) |
|
|
2,511 |
General and administrative |
|
|
3,484 |
|
|
3,210 |
|
|
(60) |
|
|
6,634 |
Operating loss |
|
|
(4,839) |
|
|
(4,135) |
|
|
— |
|
|
(8,974) |
Interest expense |
|
|
— |
|
|
(609) |
|
|
— |
|
|
(609) |
Forgiveness of note payable and accrued interest |
|
|
— |
|
|
607 |
|
|
— |
|
|
607 |
Interest and other income |
|
|
36 |
|
|
— |
|
|
— |
|
|
36 |
Consolidated net loss |
|
|
(4,802) |
|
|
(4,138) |
|
|
— |
|
|
(8,940) |
Total assets |
|
|
176,682 |
|
|
37,335 |
|
|
(70,278) |
|
|
143,739 |
Finance lease ROU assets |
|
|
— |
|
|
25,695 |
|
|
— |
|
|
25,695 |
Operating lease ROU assets |
|
|
3,487 |
|
|
— |
|
|
— |
|
|
3,487 |
Fixed assets, net |
|
|
— |
|
|
9,821 |
|
|
— |
|
|
9,821 |
Intangible assets, net |
|
|
5,164 |
|
|
— |
|
|
— |
|
|
5,164 |
Amortization of ROU assets |
|
|
— |
|
|
416 |
|
|
— |
|
|
416 |
Depreciation expense |
|
|
— |
|
|
306 |
|
|
— |
|
|
306 |
Amortization of intangible assets |
|
|
88 |
|
|
— |
|
|
— |
|
|
88 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Biopharmaceuticals |
|
Bioprocessing |
|
|
|
|
Three Months Ended September 30, 2020 (in thousands) |
|
(iBio, Inc.) |
|
(iBio CDMO) |
|
Eliminations |
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues - external customers |
|
$ |
207 |
|
$ |
203 |
|
$ |
— |
|
$ |
410 |
Revenues - intersegment |
|
|
238 |
|
|
210 |
|
|
(448) |
|
|
— |
Cost of goods sold |
|
|
54 |
|
|
53 |
|
|
— |
|
|
107 |
Gross profit |
|
|
338 |
|
|
413 |
|
|
(448) |
|
|
303 |
Research and development |
|
|
235 |
|
|
1,845 |
|
|
(218) |
|
|
1,862 |
General and administrative |
|
|
2,672 |
|
|
2,923 |
|
|
(230) |
|
|
5,365 |
Operating loss |
|
|
(2,569) |
|
|
(4,355) |
|
|
— |
|
|
(6,924) |
Interest expense |
|
|
— |
|
|
(614) |
|
|
— |
|
|
(614) |
Interest and other income |
|
|
3 |
|
|
1 |
|
|
— |
|
|
4 |
Consolidated net loss |
|
|
(2,566) |
|
|
(4,968) |
|
|
— |
|
|
(7,534) |
Total assets |
|
|
132,207 |
|
|
33,320 |
|
|
(48,272) |
|
|
117,255 |
Finance lease ROU assets |
|
|
— |
|
|
27,201 |
|
|
— |
|
|
27,201 |
Fixed assets, net |
|
|
— |
|
|
3,834 |
|
|
— |
|
|
3,834 |
Intangible assets, net |
|
|
1,236 |
|
|
— |
|
|
— |
|
|
1,236 |
Amortization of ROU assets |
|
|
— |
|
|
415 |
|
|
— |
|
|
415 |
Depreciation expense |
|
|
— |
|
|
97 |
|
|
— |
|
|
97 |
Amortization of intangible assets |
|
|
72 |
|
|
— |
|
|
— |
|
|
72 |
|